CONTRIBUTION A L'ETUDE DES EPITHELIOMAS DE LA SOUS-CLOISON NASALE.BAUDO F.1977; ; S.L.; DA. 1977; PP. 1-43; BIBL. 4 P.; (THESE DOCT. MED.; MONTPELLIER)Thesis

SENSITIZATION OF STABILIZED FIBRIN TO UREA DISPERSION BY UNDILUTED PLASMA AND SERUM.DE CATALDO F; BAUDO F.1977; ACTA HAEMATOL.; SUISSE; DA. 1977; VOL. 58; NO 2; PP. 79-83; BIBL. 4 REF.Article

PLASMA FACTORS AND THROMBASTHEMIC PLATELETSDE CATALDO F; BAUDO F.1981; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1981; VOL. 48; NO 3; PP. 511-512; BIBL. 5 REF.Article

LONG-TERM EVALUATION OF KNEE-JOINT FUNCTION AFTER SYNOVECTOMY IN HAEMOPHILIASCARPONI R; SILVELLO L; LANDONIO G et al.1982; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1982; VOL. 52; NO 2; PP. 337-338; BIBL. 3 REF.Article

HEREDITARY HYPOPROTHROMBINAEMIA. TRUE DEFICIENCY OF FACTOR II = HYPOPROTHROMBINEMIE HEREDITAIRE. INSUFFISANCE VRAIE EN FACTEUR IIBAUDO F; DE CATALDO F; JOSSO F et al.1972; ACTA HAEMATOL.; SUISSE; DA. 1972; VOL. 47; NO 4; PP. 243-249; BIBL. 14REF.Serial Issue

LES EPITHELIOMAS PRIMITIFS DE LA SOUS-CLOISON NASALEPOURQUIER H; FABRE L; GUERRIER B et al.1979; ANN. OTO-LARYNGOL. CHIR. CERVICO-FACIALE; FRA; DA. 1979; VOL. 96; NO 6; PP. 387-397; ABS. ENG; BIBL. 16 REF.Article

Abnormal platelet von Willebrand factor (vWF) as a marker of abnormal function in megakaryocytic dysplasiaDE CATALDO, F; BAUDO, F; REDAELLI, R et al.American journal of hematology. 1995, Vol 48, Num 3, pp 155-157, issn 0361-8609Article

Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (Aα 16 Arg → His)BÖGLI, C; HOFER, A; BAUDO, F et al.Haemostasis. 1992, Vol 22, Num 1, pp 7-11, issn 0301-0147Article

The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complicationsBAUDO, F; REDAELLI, R; CAIMI, T. M et al.Thrombosis research. 2000, Vol 99, Num 1, pp 21-24, issn 0049-3848Article

Novel surgical approach to pseudotumour of ilium in haemophiliaBELLINAZZO, P; SILVELLO, L; CAIMI, M. T et al.Lancet (British edition). 1989, Vol 2, Num 8675, pp 1333-1334, issn 0140-6736, 2 p.Article

Fibrinogens Bern IV, Bern V and Milano XI : three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aα-chainSTUCKI, B; ZENHÄUSERN, R; BIEDERMANN, B et al.Blood coagulation & fibrinolysis. 1999, Vol 10, Num 2, pp 93-99, issn 0957-5235Article

Two novel mutations at 373 codon of FVIII gene detected by DGGEACQUILA, M; CAPRINO, D; PECORARA, M et al.Thrombosis and haemostasis. 1993, Vol 69, Num 4, pp 392-393, issn 0340-6245Article

Local hemostasis after tooth extraction in patients with abnormal hemostatic function. Use of human fibrinogen concentrateBAUDO, F; DE CATALDO, F; GATTI, R et al.Haemostasis. 1985, Vol 15, Num 6, pp 402-404, issn 0301-0147Article

Immune status of asymptomatic HIV-infected hemophiliacs : randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrateMANNUCCI, P. M; GRINGERI, A; DE BIASI, R et al.Thrombosis and haemostasis. 1992, Vol 67, Num 3, pp 310-313, issn 0340-6245Article

Acquired selective factor X deficiency in acute nonlymphocytic leukemiaCAIMI, M. T; REDAELLI, R; CATTANEO, D et al.American journal of hematology. 1991, Vol 36, Num 1, pp 65-66, issn 0361-8609, 2 p.Article

Prothrombin-antibody coexistent with lupus anticoagulant (LA) : clinical study and immunochemical characterizationBAUDO, F; REDAELLI, R; PEZZETTI, L et al.Thrombosis research. 1990, Vol 57, Num 2, pp 279-287, issn 0049-3848Article

Emergency treatment with recombinant tissue plasminogen activator of pulmonary embolism in a pregnant woman with antithrombin III deficiencyBAUDO, F; CAIMI, T. M; REDAELLI, R et al.American journal of obstetrics and gynecology. 1990, Vol 163, Num 4, pp 1274-1275, issn 0002-9378, 1Article

Fibrinogen Milano V: A congenital dysfibrinogenaemia with a γ275 Arg→Cys substitutionSTEINMANN, C; BÖGLI, C; JUNGO, M et al.Blood coagulation & fibrinolysis. 1994, Vol 5, Num 4, pp 463-471, issn 0957-5235Article

Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacsMANNUCCI, P. M; GRINGERI, A; ZANETTI, A et al.American journal of hematology. 1988, Vol 29, Num 4, pp 211-214, issn 0361-8609Article

Recurrent mutations and three novel rearrangements in the factor VIII gene of hemophilia A patients of Italian descentCASULA, L; MURRU, S; MORI, P. G et al.Blood. 1990, Vol 75, Num 3, pp 662-670, issn 0006-4971Article

Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: A multicenter collaborative family studyBUCCIARELLI, P; ROSENDAAL, F. R; TRIPODI, A et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 4, pp 1026-1033, issn 1079-5642Article

Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates : a retrospective evaluationMORFINI, M; MANNUCCI, P. M; BAUDO, F et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, Num 2, pp 178-182, issn 0042-9007Article

Markers of procoagulant imbalance in patients with inherited thrombophilic syndromesMANNUCCI, P. M; TRIPODI, A; BOTTASSO, B et al.Thrombosis and haemostasis. 1992, Vol 67, Num 2, pp 200-202, issn 0340-6245Article

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies : A four-year prospective study from the Italian registryFINAZZI, G; BRANCACCIO, V; BAUDO, F et al.The American journal of medicine. 1996, Vol 100, Num 5, pp 530-536, issn 0002-9343Article

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications : a controlled double-blind, randomized, multicenter studyBAUDO, F; CAIMI, T. M; ROSSI, R et al.Intensive care medicine (Print). 1998, Vol 24, Num 4, pp 336-342, issn 0342-4642Article